Merck makes $9.5 billion acquisition

Merck & Co. Inc. is acquiring Cubist Pharmaceuticals Inc., a deal worth an estimated $9.5 billion. The deal represents a price of $102 per share in cash for Cubist Pharmaceuticals (NASDAQ:CBST), which is one of the largest antibiotic manufacturers in the world, and it gives Merck a stronger presence in the hospital acute care segment...